BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 22380539)

  • 1. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
    Zupan J; Komadina R; Marc J
    J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
    Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
    Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclasts are not activated in middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
    J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
    Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
    J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
    Shang M; Lin L; Cui H
    Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures.
    D'Amelio P; Roato I; D'Amico L; Veneziano L; Suman E; Sassi F; Bisignano G; Ferracini R; Gargiulo G; Castoldi F; Pescarmona GP; Isaia GC
    Osteoporos Int; 2011 Nov; 22(11):2869-77. PubMed ID: 21116815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bone resorption genes in osteoarthritis and in osteoporosis.
    Logar DB; Komadina R; Prezelj J; Ostanek B; Trost Z; Marc J
    J Bone Miner Metab; 2007; 25(4):219-25. PubMed ID: 17593491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.
    Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.
    Zhang PF; Pan L; Luo ZY; Zhao HJ; Cai SX
    COPD; 2013 Dec; 10(6):650-6. PubMed ID: 23845033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
    Liu WJ; Jiang ZM; Chen Y; Xiao PT; Wang ZY; Huang TQ; Liu EH
    J Ethnopharmacol; 2020 Jul; 257():112871. PubMed ID: 32325182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
    Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
    Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
    Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis.
    Bai P; Sun Y; Jin J; Hou J; Li R; Zhang Q; Wang Y
    Respir Res; 2011 Dec; 12(1):157. PubMed ID: 22176920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients.
    Andersson MK; Lundberg P; Ohlin A; Perry MJ; Lie A; Stark A; Lerner UH
    Arthritis Res Ther; 2007; 9(1):R18. PubMed ID: 17316439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
    Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.